@article{94275, author = {Shui T and Shi C and Jing Z and Yang D and Zhu J}, title = {Case Report: Rifampicin-Induced Thrombocytopenia in a Patient with Borderline Lepromatous Leprosy.}, abstract = {
Rifampicin is a highly effective antibacterial drug and an important component of multidrug therapy used to treat leprosy. Side effects of rifampicin are rare with the once-a-month dosage regimen of anti-leprosy multidrug therapy. Here, we report a case of rifampicin-induced thrombocytopenia during anti-leprosy treatment. Although rare, this potential side effect merits attention.
}, year = {2020}, journal = {The American journal of tropical medicine and hygiene}, month = {08/2020}, issn = {1476-1645}, doi = {10.4269/ajtmh.20-0211}, language = {eng}, }